US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity

被引:0
|
作者
G Gomez
F C Stanford
机构
[1] Brigham and Women’s Hospital,Department of Surgery
[2] Harvard Medical School,Urology
[3] Weight Center,Department of Medicine
[4] Gastrointestinal Unit,Department of Pediatrics
[5] Massachusetts General Hospital,Endocrinology
[6] Massachusetts General Hospital,undefined
[7] Harvard Medical School,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:495 / 500
页数:5
相关论文
共 50 条
  • [31] Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labels
    Conrado, Daniela J.
    Rogers, Hobart L.
    Zineh, Issam
    Pacanowski, Michael A.
    PHARMACOGENOMICS, 2013, 14 (02) : 215 - 223
  • [32] FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labels
    Yao, Hui
    Rayburn, Elizabeth R.
    Shi, Qiang
    Gao, Liang
    Hu, Wenjie
    Li, Haibo
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2017, 54 (01) : 1 - 17
  • [33] A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches
    Matt Fisher
    Kapil Rawal
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 1074 - 1080
  • [34] A Detailed Analysis of the Past 20 Years of US FDA-Approved Prescription to Over-the-Counter Switches
    Fisher, Matt
    Rawal, Kapil
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (05) : 1074 - 1080
  • [35] Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment
    Cousin, Margot A.
    Ebbert, Jon O.
    Wiinamaki, Amanda R.
    Urban, Mark D.
    Argue, David P.
    Ekker, Stephen C.
    Klee, Eric W.
    PLOS ONE, 2014, 9 (03):
  • [36] Deuterated Drug Molecules: Focus on FDA-Approved Deutetrabenazine
    DeWitt, Sheila H.
    Maryanoff, Bruce E.
    BIOCHEMISTRY, 2018, 57 (05) : 472 - 473
  • [37] Miltefosine, an FDA-approved drug for the 'orphan disease', leishmaniasis
    Berman, Jonathan
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (06): : 727 - 735
  • [39] Novel FDA-approved zavegepant drug for treating migraine
    Ahmed, Usaid
    Saleem, Muhammad Meeran
    Osman, Mohamed Ashraf
    Shamat, Shamat Fathi
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 923 - 925
  • [40] Ocular toxicities of FDA-approved antibody drug conjugates
    Vetsa, Shaurey
    Zhang, Stephanie
    Kay, Walker
    Kelkar, Neil
    Ghosh, Arko
    Alam, Suhail
    Hoopes, Phillip C.
    Moshirfar, Majid
    CUTANEOUS AND OCULAR TOXICOLOGY, 2024, 43 (04) : 316 - 327